Unusual 11 Mid-Day Movers 10/2: (XTLB) (RLD) (FHCO) Higher; (ENPH) (WILN) (ISR) Lower - InvestingChannel

May 4, 2024

Unusual 11 Mid-Day Movers 10/2: (XTLB) (RLD) (FHCO) Higher; (ENPH) (WILN) (ISR) Lower

by Street Insider061

XTL Biopharmaceuticals (Nasdaq: XTLB) 93.3% HIGHER; ripping on news from Eli Lilly & Co., which announced that it will discontinue development of tabalumab­ — being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) — due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns. ­­­­

RealD (NYSE: RLD) 27.9% HIGHER; On October 1, 2014, Starboard Value LP delivered a letter to Michael V. Lewis, Chairman and Chief Executive Officer of the Issuer, with a copy to the Issuer’s Board of Directors, proposing to acquire in a